Carmella van de Ven

3.8k citations

151 papers · 2.9k indexed · h-index 31

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 56
Immunology top 2%
- Immune Cell Function and Interaction 37
- Immune Response and Inflammation 19
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 15
- Blood disorders and treatments 11
Oncology top 5%
- CAR-T cell therapy research 18
Transplantation top 5%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 34
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 20

Co-authors: Mitchell S. Cairo Y Suen MS Cairo Janet Ayello Prakash Satwani M.B. Bradley JM Plunkett Erin Morris
Cited by: Hematology Immunology Genetics
Journals: Journal of Clinical Oncology (3 papers)Blood (39 papers)The Journal of Immunology (1 paper)
Partner nations: United States Singapore Switzerland

In The Last Decade

Carmella van de Ven

149 papers receiving 2.9k citations

Peers

Countries citing papers authored by Carmella van de Ven

Since Specialization

Citations

This map shows the geographic impact of Carmella van de Ven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmella van de Ven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmella van de Ven more than expected).

Fields of papers citing papers by Carmella van de Ven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmella van de Ven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmella van de Ven. The network helps show where Carmella van de Ven may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carmella van de Ven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carmella van de Ven Line = papers co-authored together Carmella van de Ven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial Frontiers in Neurology ·Suzanne Braniecki,Elliott Vichinsky,Mark C. Walters,Shalini Shenoy,Qiuhu Shi,Theodore B. Moore,Julie‐An Talano,Susan K. Parsons,Allyson Flower,Anne Panarella,Sandra Fabricatore,Erin Morris,Harshini Mahanti,Jordan Milner,Robert C. McKinstry,Christine Duncan,Carmella van de Ven,Mitchell S. Cairo	2024	0
2	Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant Bone Marrow Transplantation ·Susan K. Parsons,Angie Mae Rodday,Ruth Ann Weidner,Erin Morris,Suzanne Braniecki,Shalini Shenoy,Julie‐An Talano,Theodore B. Moore,Anne Panarella,Allyson Flower,Jordan Milner,Sandra Fabricatore,Harshini Mahanti,Carmella van de Ven,Qiuhu Shi,Mitchell S. Cairo	2022	4
3	Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial Journal for ImmunoTherapy of Cancer ·Jessica Hochberg,Jaclyn Basso,Qiuhu Shi,Liana Klejmont,Allyson Flower,Kristina Bortfeld,Lauren Harrison,Carmella van de Ven,Chitti R. Moorthy,Humayun Islam,Perry Gerard,Stephan D. Voss,Mitchell S. Cairo	2022	8
4	Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease Frontiers in Immunology ·Yaya Chu,Julie‐An Talano,Lee Ann Baxter‐Lowe,James Verbsky,Erin Morris,Harshini Mahanti,Janet Ayello,Carolyn A. Keever-Taylor,Bryon D. Johnson,Rona Singer Weinberg,Qiuhu Shi,Theodore B. Moore,Sandra Fabricatore,Brenda J. Grossman,Carmella van de Ven,Shalini Shenoy,Mitchell S. Cairo	2022	1
5	The Safety, Feasibility, and Efficacy of Ganciclovir Prophylaxis through Day +100 in Pediatric Allogeneic Stem Cell Transplantation (AlloSCT) Recipients: Bone Marrow Suppression May Limit Effectiveness Transplantation and Cellular Therapy ·Liana Klejmont,Allyson Flower,Jordan Milner,M. D. Espinosa Aguilar,Lauren Harrison,Carmella van de Ven,Mitchell S. Cairo	2021	1
6	Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56^Dim NK cells Innate Immunity ·Evan Shereck,Nancy S. Day,Aradhana Awasthi,Janet Ayello,Yaya Chu,Catherine McGuinn,Carmella van de Ven,Megan S. Lim,Mitchell S. Cairo	2019	8
7	A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia Biology of Blood and Marrow Transplantation ·Stacey Zahler,Monica Bhatia,Angela Ricci,Sumith Roy,Erin Morris,Lauren Harrison,Carmella van de Ven,Sandra Fabricatore,K. Wolownik,Erin Cooney-Qualter,Lee Ann Baxter‐Lowe,Paul Luisi,Olga Militano,Morris Kletzel,Mitchell S. Cairo	2016	21
8	Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice Cancer Immunology Research ·Yaya Chu,Jessica Hochberg,Ashlin Yahr,Janet Ayello,Carmella van de Ven,Matthew J. Barth,Myron S. Czuczman,Mitchell S. Cairo	2014	143
9	Enhanced Survival During Experimental Listeria monocytogenes Sepsis in Neonatal Mice Prophylactically Treated With Th1 and Macrophage Immunoregulatory Cytokines and Mediators The Pediatric Infectious Disease Journal ·Mark B. Geyer,Kavita Radhakrishnan,Carmella van de Ven,Mandhir Suri,Janet Ayello,Mitchell S. Cairo	2014	2
10	A comparison of immune reconstitution and graft‐versus‐host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients British Journal of Haematology ·Mark B. Geyer,Judith S. Jacobson,Jason Freedman,Diane George,Ginny Moore,Carmella van de Ven,Prakash Satwani,Monica Bhatia,James H. Garvin,M.B. Bradley,Lauren Harrison,Erin Morris,Phyllis Della‐Latta,Joseph E. Schwartz,Lee Ann Baxter‐Lowe,Mitchell S. Cairo	2011	37
11	Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality British Journal of Haematology ·Diane George,Nader Kim El‐Mallawany,Zhezhen Jin,Mark B. Geyer,Phyllis Della‐Latta,Prakash Satwani,James H. Garvin,M.B. Bradley,Monica Bhatia,Carmella van de Ven,Erin Morris,Joseph E. Schwartz,Mitchell S. Cairo	2011	22
12	Differential gene expression signatures of adult peripheral blood vs cord blood monocyte-derived immature and mature dendritic cells Experimental Hematology ·Hong Jiang,Carmella van de Ven,Laxmi Baxi,Prakash Satwani,Mitchell S. Cairo	2009	19
13	Birth weight references for triplets American Journal of Obstetrics and Gynecology ·S.-J. Min,Barbara Luke,Linda Min,Ruta Misiunas,Clark Nugent,Carmella van de Ven,D. Martin,Víctor Hugo González-Quintero,Sue Eardley,Frank R. Witter,Jill Mauldin,Roger Newman	2004	21
14	Differential Gene Expression Patterns by Oligonucleotide Microarray of Basal versus Lipopolysaccharide-Activated Monocytes from Cord Blood versus Adult Peripheral Blood The Journal of Immunology ·Hong Jiang,Carmella van de Ven,Prakash Satwani,Laxmi Baxi,Mitchell S. Cairo	2004	39
15	Assessment of Minimal Residual Disease in Childhood Non-Hodgkin Lymphoma by Polymerase Chain Reaction Using Patient-Specific Primers Journal of Pediatric Hematology/Oncology ·Vani J. Sabesan,Mitchell S. Cairo,Mark A. Lones,Sherrie L. Perkins,Erin Morris,Richard Sposto,Carmella van de Ven,Bruce Shiramizu	2003	14
16	A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs Cytotherapy ·Francisco Bracho,Carmella van de Ven,Ellen M. Areman,Rose Hughes,Virginia Davenport,M.B. Bradley,J.-W. Cai,Mitchell S. Cairo	2003	16
17	Ex vivo expansion, maturation, and activation of umbilical cord blood–derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7 Experimental Hematology ·Kathleen L Robinson,Janet Ayello,Rose Hughes,Carmella van de Ven,Linda Issitt,Joanne Kurtzberg,Mitchell S. Cairo	2002	41
18	Results of a phase I/II trial of recombinant human granulocyte- macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils Blood ·MS Cairo,R D Christensen,LS Sender,R Ellis,Joseph Rosenthal,Carmella van de Ven,Carrie C. Worcester,JM Agosti	1995	55
19	Immunomagnetic Separation of CD34 ⁺ Cells from Human Bone Marrow, Cord Blood, and Mobilized Peripheral Blood Journal of Hematotherapy ·Lori Ishizawa,Giao Hangoc,Carmella van de Ven,Mitchell S. Cairo,J Burgess,Virginia H. Mansour,Adrian P. Gee,A Hardwick,Christie M. Traycoff,Edward F. Srour,Robert S. Hoffman,Ping‐Yee Law	1993	18
20	Immunomagnetic Positive Selection and Colony Culture of CD34 ⁺ Cells from Blood Journal of Hematotherapy ·Ping‐Yee Law,Lori Ishizawa,Carmella van de Ven,J Burgess,A Hardwick,Mary T. Plunkett,Adrian P. Gee,Mitchell S. Cairo	1993	15

About Carmella van de Ven

Carmella van de Ven is a scholar working on Hematology, Genetics and Immunology, having authored 151 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (56 papers), Immune Cell Function and Interaction (37 papers), Lymphoma Diagnosis and Treatment (34 papers), Acute Lymphoblastic Leukemia research (20 papers), Immune Response and Inflammation (19 papers), CAR-T cell therapy research (18 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Blood disorders and treatments (11 papers). The work is most often cited by research in Hematology (1.1k citations), Immunology (1.1k citations) and Genetics (361 citations). Carmella van de Ven has collaborated with scholars based in United States, Singapore and Switzerland. Frequent co-authors include Mitchell S. Cairo, Y Suen, MS Cairo, Janet Ayello, Prakash Satwani, M.B. Bradley, JM Plunkett, Erin Morris, John Qian and Eva Knoppel. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact